Research Article

Complications, Not Minimally Invasive Surgical Technique, Are Associated with Increased Cost after Esophagectomy

Table 3

Multivariate regression analysis.

VariableAll cases Cases without complications Cases with complications
Coefficient valueCoefficient valueCoefficient value

Complications$17,385<0.001

Age (y)$6950.001$2400.196$8040.025

HTN−$21,2260.000−$1,4380.770−$33,3240.001

CAD$16,1890.006−$5,8310.502$22,8380.008

Preop ChemoXRT−$5,1730.252$6,3170.186−$10,6600.119

COPD−$7,1180.341$5,1560.555−$17,1710.152

CHF$2,9950.770−$4,5220.745$6,5470.680

Diabetes−$6300.910$9,9010.142−$2160.980

Zubrod symptomatic$900.984$4,8870.270$2,1970.777

ASA class
 II111
 III$13,6910.076$7,4060.246$28,6760.053
 IV$47,180<0.001n/a$60,2940.003

Procedure
 THE111
 Open$8,3320.308$2,3040.746$13,8650.319
 Hybrid−$2,5810.698−$6,9880.259$13,8580.907
 MIE$9,1270.216$6,4570.353$1,3750.909

Constant−$17,1700.275$2,8450.838−$11,7530.655

Observations803842

R-squared.5546.4349.6713

THE: transhiatal esophagectomy. MIE: minimally invasive esophagectomy. HTN: hypertension. CAD: coronary artery disease. CTS: cardiothoracic surgery. XRT: radiotherapy. COPD: chronic obstructive pulmonary disease. CHF: congestive heart failure. ASA: American Society of Anesthesiologist.